Haiwei Xu
- Co-authors
- Hang ZhangHong‐Min LiuZhe‐Sheng ChenCharles R. AshbyYehuda G. AssarafShufeng LiMingliang ZhangHai–Ling Qiao
- Topics
- Histone Deacetylase Inhibitors Research (3 papers)Spine and Intervertebral Disc Pathology (3 papers)Drug Transport and Resistance Mechanisms (3 papers)
- Cited by
- OncologyMolecular BiologyToxicology
- Partner nations
- ChinaNew ZealandUnited States
In The Last Decade
Haiwei Xu
24 papers receiving 513 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 266
- Oncology 127
- Organic Chemistry 76
- Biomedical Engineering 59
- Biomaterials 46
Countries citing papers authored by Haiwei Xu
This map shows the geographic impact of Haiwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiwei Xu more than expected).
Fields of papers citing papers by Haiwei Xu
This network shows the impact of papers produced by Haiwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiwei Xu. The network helps show where Haiwei Xu may publish in the future.
Co-authorship network of co-authors of Haiwei Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Haiwei Xu. A scholar is included among the top collaborators of Haiwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiwei Xu. Haiwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 18 | |
| 5 | 10 | |
| 6 | 12 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 16 | |
| 10 | 1 | |
| 11 | 8 | |
| 12 | 3 | |
| 13 | 213 | |
| 14 | 7 | |
| 15 | 28 | |
| 16 | 14 | |
| 17 | 33 | |
| 18 | 16 | |
| 19 | 6 | |
| 20 | 21 |
About Haiwei Xu
Haiwei Xu is a scholar working on Pharmacology, Toxicology and Pharmacology, having authored 27 papers that have together received 518 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (3 papers), Spine and Intervertebral Disc Pathology (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Oncology (127 citations), Molecular Biology (266 citations) and Toxicology (13 citations). Haiwei Xu has collaborated with scholars based in China, New Zealand and United States. Frequent co-authors include Hang Zhang, Hong‐Min Liu, Zhe‐Sheng Chen, Charles R. Ashby, Yehuda G. Assaraf, Shufeng Li, Hong‐Min Liu, Mingliang Zhang, Hai–Ling Qiao and Na Gao. Their work appears in journals such as International Journal of Pharmaceutics, Biochemical Pharmacology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.